Table III.
A, Tumoral immune parameters in all cases | |||||
---|---|---|---|---|---|
Parameters | Cases, n | Status of death | Mean OS, months | Log-Rank χ2 | P-value |
TILs | |||||
High | 44 | 12 | 49.25 | 11.198 | 0.001 |
Low | 19 | 12 | 24.21 | ||
TLSs | |||||
High | 43 | 12 | 48.14 | 6.501 | 0.011 |
Low | 20 | 12 | 33.40 | ||
TILs-TLSs | |||||
High | 32 | 6 | 53.03 | 12.148 | <0.001 |
Low | 31 | 18 | 33.42 | ||
gcCD8+ TILs | |||||
High | 23 | 1 | 57.83 | 13.322 | <0.001 |
Low | 32 | 17 | 36.16 | ||
B, Tumoral immune parameters in pTN III stage cases | |||||
Parameters | Cases, n | Status of death | Mean OS, months | Log-Rank χ2 | P-value |
TILs | |||||
High | 12 | 10 | 30.33 | 3.527 | 0.06 |
Low | 15 | 10 | 18.58 | ||
TLSs | |||||
High | 18 | 11 | 19.11 | 3.089 | 0.079 |
Low | 9 | 9 | 18.89 | ||
TILs-TLSs | |||||
High | 10 | 5 | 35.50 | 6.310 | 0.012 |
Low | 17 | 15 | 19.00 | ||
gcCD8+ TILs | |||||
High | 5 | 0 | – | 9.334 | 0.002 |
Low | 17 | 15 | 18.65 |
Values in bold indicate P<0.05. TILs, tumor infiltrating lymphocytes; TLSs, tertiary lymphoid structures.